- Relugolix, sold
under the
brand names Orgovyx and
Relumina among others, is a gonadotropin-releasing
hormone antagonist (GnRH
receptor antagonist) medication...
- Endometriosis;
Uterine fibroids Non-peptide Oral
Phase III 9,730
Relugolix Relumina Uterine fibroids,
prostate cancer Non-peptide Oral 2019 44,900 Notes: Launch/status...
-
United States and
Canada was
followed by that of
relugolix (brand name
Relumina), the next second-generation GnRH antagonist, in ****an in
January 2019...
- and
orally active GnRH antagonists,
elagolix (Orilissa) and
relugolix (
Relumina), were
introduced for
medical use in 2018 and 2019, respectively. But they...
